Diagnostic and Treatment of Early Disseminated Lyme Disease

Diagnostic Approach

The Centers for Disease Control and Prevention recommends a two-tiered serologic approach for the diagnosis of early disseminated Lyme disease, consisting of an enzyme-linked immunosorbent assay (ELISA) or indirect immunofluorescence assay, followed by a Western immunoblot for confirmation of positive or equivocal results 1, 2
Patients with early disseminated Lyme disease typically exhibit strong serologic reactivity with characteristic immunoglobulin G (IgG) profiles on Western immunoblot 1, 2
Serologic tests may be negative early in the infection, as antibody production can take several weeks 2

For patients with neurological manifestations, such as cerebral or spinal parenchymal involvement, intravenous antibiotics are recommended (strong recommendation) 3, 4
For patients with cardiac manifestations, such as Lyme carditis, oral antibiotics are recommended, with options including doxycycline, amoxicillin, cefuroxime axetil, or azithromycin 3, 4
The total duration of treatment is 14-21 days 3, 4
For patients with arthritis or musculoskeletal manifestations, oral antibiotics are recommended for 14-21 days, with options including doxycycline, amoxicillin, or cefuroxime axetil 1, 2, 7

Serology may remain positive for months or years after successful treatment and cannot be used as a marker of active infection 1, 2
A positive serologic result or history of Lyme disease does not guarantee protective immunity, and reinfections have been reported 1
In cases of persistent symptoms after standard antibiotic treatment, without objective signs of reinfection or treatment failure, additional antibiotic treatment is not recommended 3, 4
In cases of suspected co-infection (anaplasmosis, babesiosis), further evaluation and specific treatment may be necessary 7, 8